0001213900-24-015030.txt : 20240216 0001213900-24-015030.hdr.sgml : 20240216 20240216193938 ACCESSION NUMBER: 0001213900-24-015030 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240214 FILED AS OF DATE: 20240216 DATE AS OF CHANGE: 20240216 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Geffken Daniel E. CENTRAL INDEX KEY: 0001314756 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40877 FILM NUMBER: 24650193 MAIL ADDRESS: STREET 1: DAMONMILL SQUARE STREET 2: SUITE 6A CITY: CONCORD STATE: MA ZIP: 01742 FORMER NAME: FORMER CONFORMED NAME: GEFFKEN DANIEL E DATE OF NAME CHANGE: 20050119 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CERO THERAPEUTICS HOLDINGS, INC. CENTRAL INDEX KEY: 0001870404 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 871088814 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 201 HASKINS WAY STREET 2: SUITE 230 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-407-2376 MAIL ADDRESS: STREET 1: 201 HASKINS WAY STREET 2: SUITE 230 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: PHOENIX BIOTECH ACQUISITION CORP. DATE OF NAME CHANGE: 20210630 4 1 ownership.xml X0508 4 2024-02-14 1 0001870404 CERO THERAPEUTICS HOLDINGS, INC. CERO 0001314756 Geffken Daniel E. 2201 BROADWAY, SUITE 705 OAKLAND CA 94612 0 1 0 0 Chief Financial Officer 0 Class A Common Stock 2024-02-14 4 J 0 10002 A 10002 D Represents shares of Class A Common Stock distributed in-kind by Phoenix Biotech Sponsor, LLC (the "Sponsor") to its members, pro rata and without consideration. /s/ Chris Ehrlich, Attorney-in-Fact 2024-02-16